Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Macrophage migration inhibitory factor

Lin Leng1, Richard Bucala

  • 1Department of Medicine, Yale University School of Medicine, New Haven, CT, USA.

Critical Care Medicine
|December 13, 2005
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating orthokeratology lens fitting and the visual quality of artificial intelligence-fitted personalized lenses in myopic children with corneal asymmetry.

Scientific reports·2026
Same author

Improved efficacy of 0.01% atropine combined with diffusion optics technology lenses for myopia control in a real-world setting in Northern China.

Photodiagnosis and photodynamic therapy·2026
Same author

Comparison of Seasonal Variation in Myopia Progression: Defocus Incorporated Multiple Segment Spectacle Lenses in Combination with 0.01% Atropine vs Orthokeratology.

Clinical ophthalmology (Auckland, N.Z.)·2026
Same author

Pathogenic role of MIF receptor (CD74) expressing T cells in inflammatory arthritis.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

The Effect of Orthokeratology Lens Decentration on Ocular and Biomechanical Measurements.

Clinical ophthalmology (Auckland, N.Z.)·2026
Same author

Improving immunotherapy responses by dual inhibition of macrophage migration inhibitory factor and PD-1.

JCI insight·2025